-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Depreciation history and growth rate from 2010 to Q1 2025.
- UNITED THERAPEUTICS Corp Depreciation for the quarter ending March 31, 2025 was $19.6M, a 32.4% increase year-over-year.
- UNITED THERAPEUTICS Corp annual Depreciation for 2024 was $71.6M, a 35.4% increase from 2023.
- UNITED THERAPEUTICS Corp annual Depreciation for 2023 was $52.9M, a 3.32% increase from 2022.
- UNITED THERAPEUTICS Corp annual Depreciation for 2022 was $51.2M, a 2.81% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)